- Home
- BNR vs GSIW Comparison
BNR vs GSIW Comparison
Compare BNR & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- GSIW
- Stock Information
- Founded
- BNR 2014
- GSIW 2016
- Country
- BNR China
- GSIW Hong Kong
- Employees
- BNR N/A
- GSIW N/A
- Industry
- BNR Medical Specialities
- GSIW
- Sector
- BNR Health Care
- GSIW
- Exchange
- BNR Nasdaq
- GSIW Nasdaq
- Market Cap
- BNR 29.1M
- GSIW 27.2M
- IPO Year
- BNR 2020
- GSIW 2023
- Fundamental
- Price
- BNR $3.86
- GSIW $1.60
- Analyst Decision
- BNR
- GSIW
- Analyst Count
- BNR 0
- GSIW 0
- Target Price
- BNR N/A
- GSIW N/A
- AVG Volume (30 Days)
- BNR 35.7K
- GSIW 2.2M
- Earning Date
- BNR 08-21-2025
- GSIW 01-01-0001
- Dividend Yield
- BNR N/A
- GSIW N/A
- EPS Growth
- BNR N/A
- GSIW N/A
- EPS
- BNR N/A
- GSIW N/A
- Revenue
- BNR $72,112,038.00
- GSIW $1,313,795.00
- Revenue This Year
- BNR $136.32
- GSIW N/A
- Revenue Next Year
- BNR N/A
- GSIW N/A
- P/E Ratio
- BNR N/A
- GSIW N/A
- Revenue Growth
- BNR 0.53
- GSIW N/A
- 52 Week Low
- BNR $2.18
- GSIW $0.35
- 52 Week High
- BNR $7.90
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- BNR 62.38
- GSIW 74.17
- Support Level
- BNR $3.06
- GSIW $1.48
- Resistance Level
- BNR $3.50
- GSIW $1.64
- Average True Range (ATR)
- BNR 0.23
- GSIW 0.13
- MACD
- BNR 0.03
- GSIW -0.02
- Stochastic Oscillator
- BNR 87.26
- GSIW 80.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.